Find uplifting stories about heroes, innovations, and solutions
847 results for "dengue vaccine"
A global research team just launched an €11 million project to bring a single-dose dengue vaccine to sub-Saharan Africa, where climate change is driving a surge in infections. The four-year initiative could protect millions from the mosquito-borne disease that's becoming a growing health threat across the continent.
Mexico signed a groundbreaking agreement with Moderna to manufacture mRNA vaccines domestically, including potential vaccines for dengue and cancer. The five-year partnership will transfer cutting-edge vaccine technology to Mexican facilities and support local scientific research.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
South Carolina's largest measles outbreak in decades has officially ended after nearly 1,000 cases, and there's encouraging news: vaccination rates are climbing both locally and nationwide. Health officials say the outbreak may have reminded parents why vaccines matter.
Sudan's Ministry of Health is ramping up vaccination campaigns to combat multiple disease outbreaks, including dengue fever and hepatitis. Health officials are using existing immunization programs to spread life-saving awareness across communities.
Scientists at Washington University have created a nose spray vaccine that completely protected mice and hamsters from bird flu infection, offering hope for preventing the next pandemic. The vaccine works better than traditional flu shots and stays effective even in people who've had previous flu vaccines.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
California health officials are encouraging at-risk residents to get vaccinated against mpox as case rates have more than quadrupled compared to last year. The vaccine provides strong protection against both strains of the virus, and most new infections are happening in unvaccinated people.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
African countries have prevented nearly one million cervical cancer deaths through expanded HPV vaccination programs since 2019, while new malaria vaccines are saving thousands of children across 25 nations. These historic health wins are generating $1.8 billion in economic benefits, though funding gaps now threaten to slow the momentum.
Scientists are fast-tracking three promising vaccines to fight the Ebola outbreak in Congo and Uganda, with clinical trials starting within months. New funding of $62 million is speeding up development of the first vaccines specifically designed for the Bundibugyo virus strain.
Iceland, Portugal, and Norway have reached the ambitious target of vaccinating 90% of girls against HPV by age 15, bringing cervical cancer elimination within reach. Since 2020, every European country has reported declining cervical cancer rates among vaccinated women. #
An FDA committee greenlighted next year's flu vaccine formulation this week, maintaining the proven update process while vaccine policy debates swirl in Washington. The decision keeps Americans on track for seasonal flu protection.
South Africa is expanding its lifesaving HPV vaccination campaign to reach every girl in the country, protecting them from cervical cancer that kills over 3,000 women annually. Since 2014, the program has already vaccinated 3.6 million girls with more than 7.2 million doses administered.
After a century with only one TB vaccine, three promising candidates are in final trials, led by South African researchers who could deliver a breakthrough by 2028. The new vaccines could prevent millions of deaths from a disease that still kills over 1.5 million people yearly.
Republican pollsters are finding overwhelming voter support for vaccines and immunization programs, helping to slow aggressive policy changes. New data shows most Americans reject vaccine skepticism and support keeping childhood vaccination recommendations.
For the first time in over three years, preventive cholera vaccination campaigns are restarting worldwide as global vaccine production has doubled. Mozambique became the first country to receive doses, with 20 million vaccines now heading to three nations hit hardest by outbreaks.
A global vaccination campaign has delivered over 100 million life-saving vaccine doses to children who missed shots during the pandemic, marking the largest catch-up effort in history. The Big Catch-Up reached 18.3 million children across 36 countries, with 12.3 million receiving their very first vaccines.
The World Health Organization is championing a vital message this World Immunization Week: vaccines protect everyone from babies to grandparents, not just children. Over the past 50 years, vaccines have saved more than 150 million lives worldwide.
Researchers worldwide are developing vaccines that could protect against multiple flu strains for years, ending the need for annual shots. Around a dozen candidates are already in clinical trials.
Showing 20 of 847